orforglipron semaglutide A clinical trial for diabetes that pit orforglipron, a diabetes and weight-loss pill developed by Eli Lilly, against oral semaglutide, made by Novo Nordisk, suggests the former pill may have the edge Foundayo vs Wegovy Pill: Oral

It changed how I feel

Pretty clever science, actually

You can use any of the point locations shown here

Partnership dead, stocks a corpse. Some investors debated holding on, hoping for a rebound, but most were livid, feeling burned by Hims safety spin and ready to dump shares at the first chance

What sets it apart from earlier compounds in the same category is its selectivity: it triggers GH release without meaningfully raising cortisol, prolactin, or other hormones that older secretagogues like GHRP-2 and GHRP-6 tended to drag up

Summary of key recent findings on the various side effects of GLP-1 RAs GLP-1 RA, glucagon-like peptide-1 receptor agonist